Welcome to the upgraded BRAC University Institutional Repository. We are currently organizing collections after a recent system upgrade. Homepage category counters may temporarily show lower numbers while syncing, but over 27,000 repository items remain safe and accessible. Please use the search bar to find theses, scholarly outputs, and institutional documents.

Review

Permanent URI for this collectionhttps://hdl.handle.net/10361/7207

Browse

Recent Submissions

Now showing 1 - 1 of 1
  • Thumbnail Image
    listelement.badge.dso-type Item ,
    Designing novel antibacterials: application of omics science
    (© 2013 AVES Ibrahim Kara, 2013) Zaman, Aubhishek M.; Razzaque, Samsad; Department of Mathematics and Natural Sciences
    Antibacterials are agents that act against pernicious bacterial pathogens by killing or inactivating them. At present, designing antibacterials have been assisted greatly by omics sciences-genomics, proteomics, metabolomics and interactomics. This review discusses different aspects of the omics sciences in simple to complex hierarchies. From the simplest of sequence analysis to more complex on the pyramid -structural, functional and interactional analysisall comprises the grand ambit of omics science. Sequence comparison can reveal novel information about drug resistance in the bacteria and thus can be of momentous significance for designing improved antibacterials. On the other hand, sequence characterization of the host protein can lead to production of effective antibiotic synthetically. Nowadays, structure based molecular designing, using computational docking techniques, has become a widely accepted routine work in drug designing processes. Moreover, new high-throughput data from microarray expression, protein-protein interaction assay are opening up a new vista for detecting more and more drug targets. Extensive focus put on to understand host-pathogen interaction on systems level has greatly accelerated the process of designing effective antibacterials against tuberculosis and many such complex diseases. Summarizing, this review exemplifies various different ways how increasingly omics science is transforming the paradigm of discovering novel antibacterials; omics approach is all set to speed up the process and bring down the expenses of the antibacterials even more in time to come.